U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 22 results

Status:
US Approved Rx (1998)
First approved in 1983

Class (Stereo):
CHEMICAL (ABSOLUTE)



Etoposide (trade name Etopophos) is a semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. It has been in clinical use for more than two decades and remains one of the most highly prescribed anticancer drugs in the world. The...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Acridine carboxamide (XR5000) is a tricyclic acridine-based (or carboxamide-based) drug with dual topoisomerase inhibitor and potential antineoplastic activities. Acridine carboxamide inhibits both topoisomerases I and II and intercalates into DNA, r...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)


Conditions:

Fostriecin, an antitumor antibiotic produced by Streptomyces pulveraceus, is a strong inhibitor of serine/threonine protein phosphatases type 2A and type 4, and inhibits the catalytic activity of partially purified Topo II (type II topoisomerase) in ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)



Daniquidone, also known as Batracylin, is a water-insoluble heterocyclic amide with potential antineoplastic activity. Daniquidone inhibits topoisomerases I and II, thereby inhibiting DNA replication and repair, and RNA and protein synthesis. Batracy...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Tafluposide (also known as F 11782) is an epipodophyllotoxin derivative patented by Pierre Fabre Medicament as an antitumor agent. Tafluposide acts as a catalytic inhibitor of topoisomerases I and II, that capable of completely inhibiting the DNA-bin...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Retelleptine (SR-95325 B) is an antitumoral agent. This ellipticine derivative exhibits high toxicity against several rodent tumor models. Retelliptine is thought to intercalate with DNA and inhibit topoisomerase II during DNA replication. A phase I ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Asulacrine, also known as CI-921, an inhibitor of topoisomerase II, participated in clinical trials phase II for the treatment of cancer. In spite of the positive and promising results, this drug showed the toxicity, phlebitis that blocks its impleme...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Chlorsulfaquinoxaline is a halogenated derivative of sulfaquixonaline, an immunosuppressive and antifungal agent used in the control of coccidiosis in poultry, rabbit, sheep, and cattle. In vitro, Chlorsulfaquinoxaline acts as a topoisomerases IIα an...
Status:
Investigational

Class (Stereo):
CHEMICAL (ACHIRAL)

Mitindomide was studied as an antineoplastic agent that inhibited the activity of the topoisomerase II. The drug underwent preclinical development; however, this study was discontinued.
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Elsamitrucin is a heterocyclic antineoplastic antibiotic isolated from the bacterium Actinomycete strain J907-21. Elsamitrucin intercalates into DNA at guanine-cytosine (G-C)-rich sequences and inhibits topoisomerase I and II, resulting in single-str...